Interventional Radiology Market Size, Share, Growth, and Industry Analysis, By Type (MRI Systems,Ultrasound Imaging Systems,CT Scanners,Angiography Systems,Fluoroscopy Systems,Biopsy Devices,OthersS), By Application (Angiography,Balloon Angioplasty,Embolization,Biopsy,Vertebroplasty-Kyphoplasty,RF Ablation), Regional Insights and Forecast to 2035
Interventional Radiology Market Overview
The global Interventional Radiology Market size is projected to grow from USD 25074.03 million in 2026 to reaching USD 73331.56 million by 2035, expanding at a CAGR of 12.66% during the forecast period.
The Interventional Radiology Market is expanding as healthcare providers increasingly adopt minimally invasive, image-guided techniques for diagnosing and treating vascular diseases, tumors, and spinal conditions. Angiography Systems represent approximately 31% of the supplied product distribution, reflecting their central role in catheter-based interventions and complex vascular procedures. Hospitals are investing in imaging platforms that combine real-time visualization, advanced navigation, and improved procedural workflow. Technologies such as computed tomography, magnetic resonance imaging, ultrasound, and fluoroscopy help physicians identify anatomical targets and guide specialized instruments. Growing demand for precise treatment, reduced procedural trauma, and efficient hospital utilization is strengthening adoption across established and developing healthcare systems.
The United States Interventional Radiology Market benefits from advanced hospital infrastructure, experienced clinical specialists, and increasing adoption of minimally invasive treatment technologies. North America represents approximately 39% of the supplied global market distribution, supported by substantial investment in diagnostic imaging and specialized intervention facilities. American hospitals are expanding image-guided procedures for cardiovascular disorders, cancer treatment, spinal conditions, and tissue diagnosis. Healthcare providers increasingly evaluate imaging equipment according to procedural accuracy, patient safety, radiation management, and operational efficiency. Manufacturers are improving angiography platforms, CT-guided intervention systems, and ultrasound technologies through advanced visualization and workflow integration. Continued investment in specialized treatment centers supports market development.
Key Findings
- Key Market Driver: Growing demand for minimally invasive vascular procedures is accelerating interventional radiology adoption, with Angiography representing approximately 29% of the supplied application distribution.
- Major Market Restraint: High equipment acquisition costs, infrastructure requirements, and radiation-management complexity restrict adoption, while Fluoroscopy Systems account for approximately 13% of the supplied product distribution.
- Emerging Trends: Artificial intelligence, advanced vessel visualization, and integrated image-guided workflows are transforming interventional technology, with Angiography Systems representing approximately 31% of the supplied product distribution.
- Regional Leadership: North America leads the Interventional Radiology Market with approximately 39% of the supplied global distribution, supported by established healthcare infrastructure and advanced procedural adoption.
- Competitive Landscape: Siemens AG leads the provisional competitive assessment with an assumed 13% market share, followed by GE Healthcare at 11%, supported by extensive diagnostic imaging portfolios and interventional technologies.
- Market Segmentation: Angiography Systems dominate product demand with approximately 31% market share, reflecting their importance in vascular imaging, catheter navigation, and complex minimally invasive procedures.
- Recent Development: GE Healthcare introduced the Allia Celeo interventional imaging system in November 2026, strengthening its angiography technology portfolio serving the 31% Angiography Systems product segment.
Interventional Radiology Market Latest Trends
The Interventional Radiology Market is increasingly influenced by artificial intelligence, advanced image reconstruction, automated procedural guidance, and integrated treatment environments. Angiography Systems account for approximately 31% of the supplied product distribution, highlighting their importance in complex vascular interventions. Manufacturers are developing platforms that combine high-resolution imaging with three-dimensional visualization, vessel mapping, and software-assisted navigation. These capabilities help clinicians interpret anatomical structures and position instruments during demanding procedures. Modern interventional suites increasingly integrate imaging equipment with procedural planning and patient information systems. Hospitals are also prioritizing automated positioning, efficient image acquisition, and radiation-dose monitoring. These improvements support greater procedural consistency and more coordinated clinical workflows.
Another important trend involves expansion of image-guided oncology treatment, targeted biopsy, and minimally invasive spinal procedures. Embolization represents approximately 16% of the supplied application distribution, reflecting demand for precise vascular intervention techniques. CT scanners and ultrasound systems are increasingly used to guide tissue sampling and thermal ablation, while angiography supports catheter-based treatment. Manufacturers are improving image fusion, anatomical navigation, and automated image processing to assist physicians during complex interventions. Hospitals are also examining ways to reduce unnecessary imaging exposure while preserving clinically useful visualization. Increasing collaboration between interventional radiologists, oncologists, surgeons, and cardiovascular specialists supports broader utilization of image-guided treatment platforms.
Interventional Radiology Market Dynamics
Driver
"Growing preference for minimally invasive treatment accelerates image-guided procedural demand."
The primary driver of the Interventional Radiology Market is increasing clinical adoption of minimally invasive techniques that can diagnose and treat conditions using targeted access rather than conventional open surgery. Angiography represents approximately 29% of the supplied application distribution, demonstrating the importance of vascular imaging and intervention. Image-guided procedures help clinicians visualize anatomical structures and position catheters, needles, or specialized treatment devices accurately. Hospitals increasingly use these techniques for vascular disease, cancer diagnosis, and selected therapeutic applications. Patients may benefit from reduced tissue disruption and shorter recovery pathways when procedures are clinically appropriate. Continued technological improvement supports wider procedural adoption.
Increasing prevalence of chronic diseases and age-related medical conditions provides another important demand driver. North America accounts for approximately 39% of the supplied regional market distribution, reflecting substantial demand within developed healthcare systems. Vascular disease, cancer, and spinal disorders often require imaging-supported diagnostic or therapeutic intervention. Hospitals are expanding multidisciplinary treatment programs that combine interventional radiology with oncology, cardiovascular care, and surgical specialties. Advanced imaging equipment supports more precise procedural planning and monitoring. Improvements in equipment availability and clinician training can broaden access to suitable interventions. Continued investment in specialized treatment infrastructure strengthens long-term market demand.
Restraint
"High equipment costs and specialized infrastructure requirements restrict wider adoption."
Capital investment remains an important restraint because interventional radiology requires sophisticated imaging systems, dedicated procedural facilities, trained personnel, and appropriate radiation-protection infrastructure. Fluoroscopy Systems account for approximately 13% of the supplied product distribution, illustrating the importance of specialized real-time imaging equipment. Hospitals must evaluate acquisition costs alongside installation, servicing, facility modifications, and equipment utilization. Smaller healthcare organizations may have difficulty supporting advanced intervention facilities when patient volumes are limited. Ongoing maintenance and technology upgrades increase ownership requirements. Manufacturers are developing more efficient workflow configurations and flexible equipment options to address these barriers. Nevertheless, infrastructure investment remains a significant purchasing consideration.
Clinical training and operational complexity create additional restraints because interventional procedures require coordinated use of sophisticated imaging equipment and specialized instruments. MRI Systems represent approximately 12% of the supplied product distribution, reflecting demand for technically advanced imaging environments. Physicians and technical staff must understand equipment operation, anatomy, procedural guidance, and patient safety requirements. MRI-guided procedures may require compatible instruments and specialized operating conditions, while X-ray-based interventions require radiation management. Hospitals must maintain suitable clinical protocols and qualified personnel. Introducing new equipment may require additional training and workflow adjustments. These requirements can delay adoption, particularly in healthcare systems with limited specialist availability.
Opportunity
"Image-guided oncology and advanced treatment technologies create significant growth opportunities."
Interventional oncology creates substantial opportunities as healthcare providers expand targeted treatments for suitable cancer patients. Embolization accounts for approximately 16% of the supplied application distribution, reflecting demand for catheter-based therapies and controlled vascular treatment. Modern angiography systems support precise visualization of tumor-related blood vessels and procedural device positioning. CT and ultrasound guidance also enable targeted biopsy and thermal ablation. Manufacturers are developing platforms with advanced image fusion and three-dimensional reconstruction to improve procedural planning. Multidisciplinary cancer-care programs increasingly incorporate minimally invasive interventions when clinically indicated. Continued development of imaging technology supports opportunities for specialized equipment suppliers.
Expanding access to image-guided procedures in developing healthcare markets provides another commercial opportunity. Asia-Pacific represents approximately 23% of the supplied regional market distribution, highlighting its potential for continued expansion. Hospitals in growing healthcare systems are investing in CT scanners, ultrasound imaging, and angiography platforms to improve diagnostic and treatment capabilities. Portable equipment and multifunctional procedural systems may help facilities expand services where infrastructure is limited. Manufacturers offering technical training, reliable maintenance, and adaptable equipment configurations can improve adoption. Increasing interest in outpatient and specialty procedures also creates opportunities for efficient clinical workflows. Continued healthcare modernization supports market development.
Challenge
"Maintaining procedural accuracy and radiation safety remains a critical clinical challenge."
Complex image-guided procedures require accurate anatomical interpretation, dependable imaging performance, and coordinated clinical decision-making. Angiography Systems represent approximately 31% of the supplied product distribution, emphasizing the importance of reliable vascular visualization. Physicians must navigate specialized instruments through potentially complicated anatomical structures while monitoring procedural progress. Imaging interruptions, positioning errors, or inadequate visualization can complicate treatment. Manufacturers are improving navigation software, image reconstruction, and equipment ergonomics to support procedural efficiency. Hospitals also require suitable training and multidisciplinary teamwork. Continued innovation must maintain a balance between sophisticated automation and appropriate physician oversight during clinical procedures.
Radiation exposure presents another challenge because angiography, fluoroscopy, and CT-guided interventions use ionizing radiation during selected procedures. Fluoroscopy Systems account for approximately 13% of the supplied product distribution, reflecting the importance of real-time X-ray guidance. Healthcare providers must optimize image acquisition according to clinical requirements while managing exposure for patients and staff. Manufacturers are developing dose-monitoring tools, improved detectors, and advanced image processing. Prolonged or technically complicated interventions may require additional imaging, increasing the importance of appropriate protocols. Hospitals also face integration challenges when connecting equipment from different suppliers. Reliable interoperability and radiation-management practices remain important market requirements.
Interventional Radiology Market Segmentation
By Types
MRI Systems: MRI Systems provide detailed soft-tissue visualization for selected interventional procedures requiring precise anatomical information. The segment represents approximately 12% of the supplied product distribution. MRI guidance may support targeted procedures involving tumors and complex soft-tissue structures. Its imaging capabilities can help clinicians distinguish anatomical features without ionizing radiation, although specialized environments and compatible instruments are necessary. Manufacturers are improving imaging speed, visualization software, and procedural integration. Hospitals evaluate MRI-based intervention according to clinical suitability, equipment availability, and operational requirements. Continued development of specialized interventional techniques may increase adoption where detailed soft-tissue imaging provides meaningful advantages.
Ultrasound Imaging Systems: Ultrasound Imaging Systems are widely used for real-time procedural guidance without exposing patients to ionizing radiation. The segment accounts for approximately 15% of the supplied product distribution. Ultrasound supports vascular access, image-guided biopsy, drainage, and selected ablation procedures. Portable equipment enables flexible use across different clinical environments. Manufacturers are improving transducer performance, Doppler imaging, image fusion, and software-assisted guidance. Clinicians value immediate visualization of suitable anatomical targets and instruments during intervention. Product development increasingly emphasizes image quality and workflow simplicity. Continued demand for portable and versatile imaging supports the importance of ultrasound within interventional radiology.
CT Scanners: CT Scanners provide detailed cross-sectional visualization for image-guided procedures involving internal lesions and complex anatomical structures. The segment represents approximately 17% of the supplied product distribution. CT guidance is important for biopsies, selected ablation procedures, drainage, and spinal interventions. High-resolution imaging helps physicians identify anatomical targets and plan instrument placement. Manufacturers are improving reconstruction speed, image quality, radiation-dose management, and procedural workflow integration. Advanced software can support more precise planning and monitoring. Hospitals increasingly evaluate CT systems according to diagnostic versatility and interventional capabilities. Continued development of minimally invasive procedures supports demand for sophisticated cross-sectional imaging platforms.
Angiography Systems: Angiography Systems provide real-time visualization of blood vessels during diagnostic and therapeutic catheter-based procedures. The category accounts for approximately 31% of the supplied product distribution. These platforms are important for angiography, embolization, balloon angioplasty, and complex vascular interventions. Modern systems integrate digital imaging, procedural positioning, navigation tools, and radiation-management capabilities. Manufacturers are developing artificial intelligence-assisted vessel visualization and advanced three-dimensional reconstruction. Hospitals increasingly require multifunctional angiography platforms capable of supporting different interventional specialties. Improved workflow and imaging consistency can support procedural efficiency. Continued demand for minimally invasive vascular treatment strengthens the segment's leading position.
Fluoroscopy Systems: Fluoroscopy Systems provide continuous X-ray imaging to guide medical instruments and monitor procedural progress. The segment represents approximately 13% of the supplied product distribution. Fluoroscopy supports catheter navigation, device positioning, spinal interventions, and selected gastrointestinal or vascular procedures. Modern systems incorporate digital image processing and exposure-control features to balance visualization with radiation management. Manufacturers are improving detector technology, equipment positioning, and workflow integration. Hospitals evaluate fluoroscopy according to procedural versatility, reliability, and lifecycle performance. Continued use of minimally invasive intervention supports demand for real-time imaging technology. Appropriate dose optimization remains important during procedures requiring extended visualization.
Biopsy Devices: Biopsy Devices support image-guided tissue sampling for diagnostic evaluation of tumors and other abnormal structures. The category accounts for approximately 7% of the supplied product distribution. Interventional radiologists use specialized needles and instruments alongside CT or ultrasound guidance to target selected lesions. Accurate sampling is important for pathology evaluation and clinical treatment planning. Manufacturers are developing devices with improved handling, targeting accuracy, and imaging compatibility. Hospitals increasingly require biopsy technologies suitable for different anatomical locations and procedural conditions. Continued emphasis on precise diagnosis and personalized medical treatment supports demand for reliable image-guided tissue acquisition technologies.
Others: The Others category includes specialized imaging equipment, navigation technologies, and procedural systems outside the principal product classifications. This segment represents approximately 5% of the supplied product distribution. These technologies may support advanced image fusion, procedural planning, or specialized interventional applications. Hospitals increasingly evaluate equipment capable of integrating with existing imaging infrastructure. Manufacturers are improving software interoperability, visualization quality, and automated guidance features. Demand depends on clinical specialization and the suitability of individual technologies for particular procedures. Continued development of integrated interventional environments creates opportunities for differentiated products serving complex treatment requirements.
By Applications
Angiography: Angiography enables physicians to visualize blood vessels for diagnosing vascular conditions and guiding catheter-based procedures. The application accounts for approximately 29% of the supplied market distribution. Digital angiography systems provide real-time imaging and support assessment of vessel anatomy. Advanced platforms may incorporate three-dimensional reconstruction, image fusion, and procedural navigation. Hospitals increasingly require angiography equipment capable of supporting different vascular specialties. Manufacturers are improving visualization and radiation-management features to address complex clinical requirements. Continued demand for minimally invasive vascular assessment and treatment strengthens the importance of angiography across specialized healthcare facilities.
Balloon Angioplasty: Balloon Angioplasty is a catheter-based treatment used to widen selected narrowed blood vessels under imaging guidance. The application represents approximately 18% of the supplied market distribution. Angiography and fluoroscopy help clinicians navigate instruments and monitor balloon positioning during intervention. Improvements in image quality and procedural navigation support management of complex vascular anatomy. Manufacturers are developing integrated imaging systems that provide dependable real-time visualization. Hospitals evaluate intervention capabilities according to clinical effectiveness, procedural efficiency, and patient safety. Continued vascular disease treatment requirements support demand for advanced imaging technology associated with balloon angioplasty procedures.
Embolization: Embolization involves intentionally blocking selected blood vessels using specialized materials delivered through catheter-based techniques. The segment represents approximately 16% of the supplied application distribution. Image guidance is essential for identifying target vessels and positioning treatment devices accurately. Embolization is used in selected vascular conditions and interventional oncology procedures. Manufacturers are improving angiography visualization, vessel mapping, and software-assisted navigation. Advanced imaging can help clinicians evaluate complex vascular anatomy and treatment coverage. Hospitals increasingly incorporate embolization into multidisciplinary care programs when clinically appropriate. Continued innovation in imaging guidance supports demand for specialized interventional equipment.
Biopsy: Biopsy involves collecting tissue samples from targeted anatomical locations for diagnostic examination. The application accounts for approximately 15% of the supplied market distribution. CT and ultrasound guidance support instrument positioning during selected procedures, particularly for deep or difficult-to-access lesions. Image-guided biopsy can provide diagnostic tissue while avoiding more extensive surgical access in appropriate patients. Manufacturers are improving needle designs, visualization technology, and procedural navigation. Hospitals increasingly require flexible imaging systems capable of supporting multiple biopsy applications. Continued demand for tissue characterization and accurate diagnosis strengthens the role of image-guided biopsy within interventional radiology.
Vertebroplasty-Kyphoplasty: Vertebroplasty-Kyphoplasty includes minimally invasive spinal procedures performed in selected patients with vertebral compression conditions. The application represents approximately 11% of the supplied market distribution. Fluoroscopy and CT provide anatomical guidance during instrument placement and treatment delivery. Physicians require clear visualization of vertebral structures and surrounding anatomy. Manufacturers are improving imaging compatibility, procedural tools, and workflow efficiency. Hospitals evaluate these procedures according to patient selection, clinical guidelines, and available specialist expertise. Demand is influenced by aging populations and spinal treatment requirements. Continued imaging development supports appropriate use of image-guided spinal interventions.
RF Ablation: RF Ablation uses controlled radiofrequency energy to treat selected tissue targets under appropriate imaging guidance. The application represents approximately 11% of the supplied market distribution. CT and ultrasound systems help physicians identify treatment locations and position specialized ablation instruments. The procedure is used for selected tumors and other clinical conditions where localized treatment is suitable. Manufacturers are developing better visualization, probe guidance, and treatment-monitoring capabilities. Interventional radiologists increasingly collaborate with oncology teams to evaluate appropriate patient care pathways. Continued improvements in targeted imaging and procedural planning support adoption of RF ablation technologies.
Interventional Radiology Market Regional Outlook
North America
North America leads the Interventional Radiology Market through extensive hospital infrastructure, advanced imaging technology, and established minimally invasive treatment programs. The region represents approximately 39% of the supplied global market distribution. The United States contributes substantial demand through cardiovascular treatment centers, oncology facilities, and specialized hospital departments. Healthcare providers increasingly invest in angiography systems, CT scanners, ultrasound imaging, and integrated procedural suites. Advanced clinical expertise supports the use of image-guided therapies across multiple specialties. Hospitals are also improving radiation management, procedural workflow, and equipment interoperability. Continued investment in modern treatment infrastructure strengthens regional market leadership.
Europe
Europe represents a major Interventional Radiology Market supported by established healthcare systems, specialized clinical training, and increasing demand for minimally invasive treatment. The region accounts for approximately 27% of the supplied global market distribution. Germany, France, the United Kingdom, Italy, and other European countries contribute through hospital modernization and advanced diagnostic imaging investment. Healthcare providers increasingly evaluate angiography, ultrasound, and CT technologies according to procedural quality and patient safety. Radiation management and equipment interoperability remain important purchasing considerations. Manufacturers are developing integrated imaging platforms and workflow assistance. Continued demand for vascular and oncological interventions supports regional market development.
Asia-Pacific
Asia-Pacific is expanding through healthcare infrastructure development, growing specialty hospital capacity, and increasing adoption of image-guided procedures. The region represents approximately 23% of the supplied global market distribution. China, Japan, India, South Korea, and other markets contribute through investment in advanced imaging and minimally invasive treatment technologies. Hospitals are developing cardiovascular, oncology, and interventional radiology services. Manufacturers are improving equipment availability and technical support across diverse healthcare settings. Demand is influenced by increasing awareness of image-guided treatment and growing clinical specialization. Continued investment in hospital modernization creates opportunities for angiography systems, CT scanners, and ultrasound technologies.
Middle East and Africa
Middle East and Africa represents an emerging Interventional Radiology Market supported by healthcare modernization, specialist hospital development, and increasing access to advanced medical imaging. The region accounts for approximately 7% of the supplied global distribution. Gulf countries contribute through investments in tertiary-care facilities, while selected African markets are developing specialized procedural capabilities. Healthcare providers increasingly evaluate imaging systems suitable for cardiovascular, oncology, and diagnostic interventions. Equipment reliability, clinical training, and service availability remain important adoption factors. Manufacturers providing adaptable platforms and technical support can strengthen regional participation. Continued healthcare infrastructure development supports gradual market expansion.
Rest of the World
Rest of the World includes developing healthcare markets where private hospital expansion and investment in diagnostic equipment are increasing access to image-guided procedures. The region represents approximately 4% of the supplied global market distribution. Latin American healthcare providers contribute through cardiovascular intervention programs, oncology services, and hospital modernization. Procurement decisions often emphasize equipment versatility, maintenance support, and total lifecycle requirements. Manufacturers are offering imaging solutions suitable for diverse facility sizes and procedural workloads. Continued clinical training and healthcare investment can improve adoption. Growing demand for minimally invasive treatment creates opportunities across specialized hospitals and regional medical centers.
List of Top Interventional Radiology Companies
- Toshiba Medical Systems Corporation
- Siemens AG
- Esaote S.P.A.
- Hitachi Medical Corporation
- Hologic Inc.
- Carestream Health
- Koninklijke Philips N.V.
- Shimadzu Corporation
- GE Healthcare
Top Two Companies with Highest Market Share
- Siemens AG: Siemens AG has a provisional assumed 13% share of the Interventional Radiology Market, supported by its Siemens Healthineers angiography platforms, advanced imaging technologies, and integrated procedural solutions.
- GE Healthcare: GE Healthcare has a provisional assumed 11% share of the Interventional Radiology Market, supported by its Allia interventional imaging portfolio, advanced visualization capabilities, and hospital imaging technologies.
Investment Analysis and Opportunities
Investment in the Interventional Radiology Market increasingly focuses on advanced imaging infrastructure, artificial intelligence, procedural automation, and integrated clinical environments. Angiography Systems represent approximately 31% of the supplied product distribution, reflecting their importance to specialized intervention facilities. Hospitals are investing in technologies capable of supporting vascular procedures, oncology treatment, and other minimally invasive applications. Improved imaging resolution and advanced navigation can strengthen procedural capabilities. Investors also evaluate equipment utilization, clinician availability, and maintenance requirements when considering healthcare infrastructure projects. Manufacturers offering integrated imaging platforms and dependable technical support may strengthen their market position. Continued demand for minimally invasive treatment supports investment opportunities.
Emerging healthcare markets create additional opportunities as specialty hospitals and advanced treatment centers expand. Asia-Pacific represents approximately 23% of the supplied regional market distribution, reflecting considerable potential for infrastructure investment. Healthcare organizations are evaluating equipment capable of supporting multiple clinical procedures within existing facilities. CT scanners, ultrasound imaging, and angiography systems can provide flexible diagnostic and therapeutic capabilities. Opportunities also exist in software modernization, equipment leasing, service contracts, and clinical training. Manufacturers offering scalable solutions and workflow integration can improve adoption. Continued growth in vascular and oncology treatment requirements supports long-term investment in interventional radiology technologies.
New Product Development
New product development increasingly emphasizes artificial intelligence-assisted imaging, advanced vessel visualization, and improved procedural guidance. Angiography Systems account for approximately 31% of the supplied product distribution, supporting innovation in integrated interventional platforms. Manufacturers are developing equipment capable of combining imaging, navigation, and procedural planning within coordinated workflows. Advanced reconstruction and image-processing technologies can improve visualization during complex procedures. Automated positioning and software-assisted guidance may reduce unnecessary workflow interruptions. Hospitals increasingly require systems that integrate with existing clinical infrastructure. Continued investment in advanced imaging supports development of technologies designed for more precise and efficient minimally invasive intervention.
Radiation management and multifunctional imaging capabilities represent additional development priorities as healthcare providers seek improved patient safety and operational flexibility. Fluoroscopy Systems represent approximately 13% of the supplied product distribution, reflecting demand for dependable real-time imaging. Manufacturers are improving detector technology, dose-monitoring functions, and automated exposure control. Ultrasound and CT platforms are also incorporating software-assisted visualization and procedural planning capabilities. Integration between different imaging modalities may provide clinicians with more comprehensive anatomical information. Equipment developers increasingly emphasize ergonomic design and compatibility with hospital information systems. These innovations support continued modernization of interventional radiology suites.
Five Recent Developments
- March 2026 – Siemens AG: Siemens Healthineers presented the Artis genio, Artis icono.explore, and Artis icono.vision angiography platforms, incorporating artificial intelligence-assisted embolization planning and advanced vascular visualization for interventional procedures. Angiography Systems represent approximately 31% of the supplied product distribution, reflecting demand for integrated imaging platforms supporting complex treatments.
- March 2026 – Esaote S.P.A.: Esaote introduced its MyLab E85 GTS and MyLab C30 GTS Edition ultrasound systems at the European Congress of Radiology, emphasizing image-guided procedures, multimodality fusion, and advanced treatment visualization. Ultrasound Imaging Systems account for approximately 15% of the supplied product distribution, highlighting demand for real-time procedural guidance.
- August 2026 – Hologic Inc.: Hologic reported FDA clearance for the Brevera breast biopsy system's replacement 9-gauge needle as part of its program to restore product availability following an earlier field safety action. Biopsy Devices represent approximately 7% of the supplied product distribution, reflecting their relevance to image-guided tissue sampling; this clearance was not a new system launch.
- September 2026 – Shimadzu Corporation: Shimadzu's Trinias C12s digital angiography system was commissioned at Father Muller Medical College Hospital in Karnataka, supporting complex cardiovascular imaging and interventional procedures. Angiography applications represent approximately 29% of the supplied application distribution, demonstrating demand for advanced vascular imaging equipment.
- November 2026 – GE Healthcare: GE Healthcare introduced its Allia Celeo ceiling-mounted interventional imaging system, featuring AI-assisted precision imaging, procedural workflow support, and advanced visualization capabilities. Angiography Systems represent approximately 31% of the supplied product distribution, reflecting the relevance of sophisticated interventional imaging platforms; the system was CE-marked and pending U.S. clearance at announcement.
Future Outlook of Interventional Radiology Market
The Interventional Radiology Market is expected to advance through continued demand for minimally invasive treatment, improved imaging accuracy, and expanding clinical applications across vascular disease, oncology, and spinal care. Hospitals will increasingly invest in imaging technologies capable of supporting complex procedures through advanced visualization and coordinated clinical workflows. Artificial intelligence, three-dimensional reconstruction, and image-guided navigation are expected to become more important components of modern intervention facilities. Manufacturers will refine equipment to improve procedural reliability, radiation management, and compatibility with hospital information systems. Continued healthcare investment and specialist training will support wider access to appropriate image-guided procedures.
Future market competition will emphasize integrated imaging platforms, multifunctional procedural capabilities, and efficient use of hospital infrastructure. Healthcare providers will increasingly evaluate equipment according to clinical effectiveness, service reliability, workflow flexibility, and lifecycle performance. Manufacturers will continue developing advanced angiography, CT, ultrasound, and fluoroscopy technologies with improved automation and visualization. Expansion of oncology intervention and vascular treatment services will create opportunities for specialized equipment suppliers. Clinical expertise and appropriate patient selection will remain essential to successful adoption. Long-term market development will depend on technology innovation, healthcare infrastructure investment, and the continued evolution of minimally invasive treatment pathways.
Interventional Radiology Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 25074.03 Million in 2026 |
|
|
Market Size Value By |
USD 73331.56 Million by 2035 |
|
|
Growth Rate |
CAGR of 12.66% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Interventional Radiology Market is expected to reach USD 73331.56 Million by 2035.
The Interventional Radiology Market is expected to exhibit a CAGR of 12.66% by 2035.
Toshiba Medical Systems Corporation,Siemens AG,Esaote S.P.A.,Hitachi Medical Corporation,Hologic Inc.,Carestream Health,Koninklijke Philips N.V.,Shimadzu Corporation,GE Healthcare are top companes of Interventional Radiology Market.
In 2025, the Interventional Radiology Market value stood at USD 22256.37 Million.